Biolingus (@Biolingus) header
Biolingus (@Biolingus) profile picture

a breakthrough platform technology for stabilising & oral drug delivery of peptides, cytokines, anti TNF alpha & vaccines

beyond convenience
Joined November 2014
Biz #partnership is all about valuing core competence of each other& derive exponential Gr% prospects in association mindsofmalady.com/2017/02/bi…
Non-invasive delivery of biological drugs:holy grail in pharmaceutical industry? bwmonline.com/2016/11/07/the… via @Business Worldwide Magazine
1
2
Technological innovation can advance the non-invasive delivery of biological drugs , says @Biolingus europeanceo.com/business-and…
1
1
Common to #NDDS tech; well ahead of times, when developed, real exciting commercial output realised; when relevant #therapy peaks #Biolingus
2015 In Review: Initial public offerings – FirstWord Pharma pllqt.it/52vNdN
1
1
2015 In Review: #Pharma's largest in-licensing deals – cancer continues to carry the day firstwordpharma.com/node/133…
3
1
Wish all a very happy & prosperous new year...let #Biolingus be trusted partner for deliverance of better healthcare to all - 2016
Knowledge pooling leading to mutual commercial success teapawt.net/Biolingus/status/63893…
Creating holobiont of partnerships taking to flux of creating value thru skill platform to flexible knowledge sharing,both product/geography
1
1
Scaling up of #Biotech R&D is tangentially different ball game getting from an orbit to another #Biolingus
Business #partnership is all about acknowledging strength of partner #pharma #biotech either is geography entrenchment or IP
Biobetters in therapies introduced post patent expiry;may eventually take share from d other products in class besides expanding market size
1
1
Biz turnaround can become integral part as SBU for some sectors-which turns around&spinning off revived biz&ensures definite revenue stream
1
1
Biz #partnership is all about acknowledging & valuing core competence of each other & derive exponential #growth prospects in association
1
2
GSK plans sirukumab filing in rheumatoid arthritis next year buff.ly/1RzKibj #pharma
3
1
Replying to @Frank_S_David
.@Frank_S_David no breakdown, but 2014 IMS report says 32% of global NMEs not available in US
2
2
3
$GILD $GLPG Upfront $725M. Consisting of $300M licensing fee + $425M equity investment. Up to $1.35B in milestones + double-digit royalties
1
2
4
~2bn getting 10x"@sharma6669: Skeptics who fail to applaud disruption/breakthrough tech - now what will they call seekingalpha.com/article/371…"
Thrilling to get in path breaking #therapy w/ #novel #drugdelivery tech being launched #market #pricing #marketshare #competitors #biolingus
2
1
Medimetrics Release IntelliCap Oral Drug Delivery System Wins Product Innovation Award pllqt.it/16DvML
3
3